Introduction
Ischemic vascular diseases are still the leading cause of death worldwide. 1 To preserve and improve the perfusion of ischemic tissues, stimulation of blood vessel growth is needed. 2 The principle mechanisms of sprout-cell into a tip cell. These in turn are characterized by filopodia that extend into the environment and guide the cell to migrate outwards of the vessel. Subsequently, the migrating tip cells are followed by proliferating stalk cells to form a new sprout. 8 Anastomosis of adjacent vessels is achieved by fusion events between tip cells. Finally, lumen formation occurs in stalk cells converting the sprout into a functional blood vessel. 9 Remarkably, the regulatory mechanisms and mediators that control the formation and behaviour of endothelial sprouts are reminiscent to sprouting and fusion events in other tube-like organ systems such as tracheal tube formation in drosophila 10 or neuronal growth. 10 The transcription factor neuronal PAS4 (NPAS4) is the highly conserved vertebrate homologue of the Drosophila bHLH-PAS protein Dysfusion. 11, 12 Dysfusion is expressed in the tracheal tube tip cells and controls the expression of genes involved in tracheal tube fusion. 13 NPAS4 belongs to the family of basic helix-loop-helix Per-Arnt-Sim [PAS] (bHLH-PAS) proteins. Typical bHLH-PAS proteins form heterodimeric protein complexes with the most conventional pairing composed of one constitutively expressed and one highly regulated protein. 14 As shown before, the specifically expressed NPAS4 dimerizes with the ubiquitous aryl hydrocarbon receptor translocator (Arnt) and transactivates the central nervous system midline enhancer element. 11, 15 Apart from the regionalized expression, it has been shown that NPAS4 is an early-response transcription factor that controls the expression of its target genes dependent on the cell-type-specific status of their regulatory elements. 16 NPAS4 is highly expressed in the brain, particularly in the limbic system 11 and plays a key role in the development of inhibitory synapses. 17 The restricted expression pattern of NPAS4 itself can be controlled by repressors such as REST as well as microRNAs. 18 As the mammalian NPAS4 and the Drosophila Dysfusion, proteins are highly conserved across species and given the fact that Dysfusion plays an important role in branching morphogenesis we here aimed to investigate the role of NPAS4 in blood vessel development.
Methods

KCl stimulation in HUVECs
HUVECs were cultured in endothelial cell basal medium containing 1% FBS in the presence of 100 mM KCl, 5 mM EGTA or 5 mM EGTA and 100 mM KCl. Cells were preincubated for 10 min with the Ca 2þ -chelator EGTA before KCl was added. RNA was extracted after 4 h and NPAS4 expression analyzed by RT-PCR.
Matrigel tube formation assay
Matrigel sprouting assay was performed as described previously. 19 
Spheroid sprouting assay
Endothelial cell spheroids were generated as published previously. 20 
Planar migration assay
Twenty-four hours after transfection, 5Â10 4 HUVECs were seeded in enhanced endothelial cell growth medium with 2% FBS in each compartment of silicone culture inserts for wound healing assays (ibidi-GmbH, Martinsried, Germany). Cells were incubated for 24 h at 37 C and 5% CO 2 to allow appropriate cell attachment. Culture inserts were removed and pictures were taken at Â5 magnification at 0 and 8 h. The cell-free area was measured using Axio Vision Rel. 4 .8 (Zeiss, Dublin, CA).
Matrigel plug assay
Experiments were performed according to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes and local ethics protocols. Growth factor reduced Matrigel (BD Biosciences, Heidelberg, Germany) was thawed overnight at 4 C on ice and mixed with heparin to a final concentration of 10 U/mL. Six-to eight-week-old female C57BL/6 Npas4 þ/þ (wildtype) and C57BL/6 Npas4 -/-17 littermates were anesthetized by the inhalation of isoflurane and 500 mL Matrigel was injected subcutaneously into the abdominal flanks. After 10 days, mice were euthanized by cervical dislocation, plugs were isolated, fixed in 4% paraformaldehyde and sectioned. Blood vessel infiltration was imaged and analysed with Zeiss Axioplan2/Axiovision Rel. 4 .8 (Zeiss, Dublin, CA). For immunohistofluorescence staining please refer to Supplementary material online.
Proteome Profile Array
HUVECs were transfected with either NPAS4-coding plasmid to overexpress NPAS4 or control plasmid as previously described. After 48 h, cells were lysed and proteome profiler array was performed according to the instructions from the manufacturer (ARY012, R&D Systems, Minneapolis, MN).
Bioinformatic analysis
A 1000 bp promotor sequence upstream to transcription start site of the human (ENSG00000179776) or zebrafish (ENSDARG00000075549) Ve-cadherin gene was retrieved from Ensembl database and scanned for a NPAS4 binding motif (CTCGTG) 21 using Regulatory Sequence Analysis Tools. 22 Only sequences with perfect identity (weight score 1.0) were considered as matching sequences.
Mosaic spheroid-sprouting assay
Mosaic spheroid sprouting assay was performed as described previously. 23 
Fish strains and morpholino injections
Zebrafish procedures were approved by the Government Veterinary Office (Regierungspr€ asidium) and were performed according to the guidelines from Directive 2010/63/EU of the European Parliament. Embryos of the tg (fli1:EGFP) line, 24 were raised and staged as previously described. 25 Fertilized eggs were kept in 0.3Â Danieau's solution at 28 C with the addition of 0.003% 1-phenyl-2-thiourea (Sigma-Aldrich, Steinheim, Germany) at 24 hpf to suppress pigmentation. To decrease NPAS4 expression in zebrafish embryos, a mixture of two specific morpholinos (MOs) targeting NPAS4 were used. A standard control MO was used for control injections. All MOs were diluted in Danieau's solution and 2 ng per morpholino injected into 1-cell or 2-cell stage embryos.
To suppress possible off-target effects, injections were performed with NPAS4 and additional p53 MOs at equal doses (see Supplementary ma terial online, Figure S3 ). MOs were purchased from Gene tools (Philomath, Corvallis, OR). For sequences, see Supplementary material online. Embryos were anaesthetized with 0.004% tricaine and imaged with an inverted ZEISS LSM 5 Live DUO high-speed confocal microscope at the Life Imaging Center, ZBSA, Freiburg, Germany.
Statistical analysis and quantification
Statistical analysis was performed using GraphPad 5.0, La Jolla, CA. Data are presented as mean±SEM and comparisons of two groups were calculated by Student's t-test (two-sided, unpaired), whereas comparisons 
Results
NPAS4 expression and regulation in endothelial cells
To address the hypothesis that NPAS4 plays a role in angiogenesis, we first investigated the expression of NPAS4 in endothelial cells. Indeed, we detected NPAS4 expression at the RNA and protein level in human umbilical vein endothelial cells (HUVECs), human coronary artery endothelial cells (HCAECs) and human microvascular endothelial cells of the heart and the lung (HMECs) ( Figure 1A and B). As NPAS4 is shown to be activity regulated in neurons, 17 we investigated if membrane depolarization in endothelial cells induces NPAS4 expression as well. Indeed, KCl stimulation in HUVECs increased NPAS4 expression ( Figure 1C and D) in a calcium-dependent manner. Pre-treatment with the Ca 2þ -chelator EGTA efficiently inhibited the stimulating effect. Thus, NPAS4 expression and regulation is not restricted to neural cells but is also present in endothelial cells.
NPAS4 overexpression increases angiogenic sprouting, branch formation and migration
To investigate the role of NPAS4 in endothelial cell sprouting and branch formation, we examined HUVECs in different in vitro sprouting assays. To avoid depletion of the dimerization partner, we also transfected Arnt in NPAS4 and control conditions. Quantification of NPAS4 overexpression in HUVECs is shown in Supplementary material online, Figure S1A and B. In the two-dimensional Matrigel tube formation, assay NPAS4 enhanced HUVEC sprouting up to 50%. Similarly, the number of branch points was increased in the presence of NPAS4 (Figure 2A and B) . In order to confirm these results by a second method, we used the three-dimensional spheroid-sprouting assay. Indeed, we obtained similar results in this assay that mimics in vivo conditions to an even greater extend. Overexpression of NPAS4 resulted in enhanced sprouting and branching ( Figure 2C and D) .
Besides sprouting and branching of endothelial cells, migration is also essential for angiogenesis. To examine the role of NPAS4 in the migratory behaviour of endothelial cells, we used the planar migration assay. Overexpression of NPAS4 in HUVECs increased migration capacity by about 50% vs. control ( Figure 2E and F). Cell viability and apoptosis assays confirmed that NPAS4 overexpression did not affect these parameters, but directly cell sprouting and migration (Supplementary material online, Figure S1E and F). Taken together, these data demonstrate that NPAS4 is a strong inducer of angiogenic endothelial cell function.
A NPAS4 
NPAS4 regulates angiogenic sprouting and branch formation
As NPAS4 induced endothelial cell sprouting and branch formation, we next asked whether NPAS4 is necessary for angiogenic activity of endothelial cells. Therefore, NPAS4 was depleted from HUVECs using two different specific siRNAs. As shown in Figure 3A and B, loss of NPAS4 resulted in decreased sprouting and branch formation of endothelial cells in the two-dimensional Matrigel tube formation assay. Along the same line, we observed a reduction of about 75% in sprouting capacity in the three-dimensional spheroid-sprouting assay, when NPAS4 expression is diminished ( Figure 3C and D). Cell viability and apoptosis assays confirmed that NPAS4 deficiency did not affect cell viability and apoptosis (Supplementary material online, Figure S1G and H). Altogether, NPAS4 is not only an inducer of sprout-and-branch formation but also necessary for the pro-angiogenic phenotype of endothelial cells.
Lack of NPAS4 in vivo reduces endothelial cell ingrowth in Matrigel plugs
Given that NPAS4 decreased angiogenic cell behaviour in vitro, we next aimed to confirm these results in vivo. As prototypic in vivo angiogenesis assay, we performed the mouse aortic ring assay (Supplementary mater ial online, Figure S2A double-positive cells ( Figure 4C) . Consistent with our in vitro findings, endothelial cells showed reduced ingrowth into the Matrigel plug in NPAS4 -/-mice compared with wildtype littermates and if stimulated with bFGF, these differences were significant ( Figure 4B ). Taken together, our data show that NPAS4 exerts pro-angiogenic effects in vitro as well as in vivo depending on the experimental setup.
VE-cadherin is a target of NPAS4
As NPAS4 is a transcription factor, we aimed to identify target genes of NPAS4 that may confer the observed pro-angiogenic effects. In Drosophila NPAS4 homologue Dysfusion targets shotgun and CG13196 which encode adhesion molecules. 26 Therefore, we hypothesized that possible targets in vertebrates are found among adhesion molecules. To address this question, a proteome profile array for adhesion proteins was performed with cell lysates of NPAS4 or control transfected HUVECs ( Figure 5A and Supplementary material online, Figure S3 ). In fact, the expression of VE-cadherin is upregulated by NPAS4. We confirmed this result by western blot analysis, which showed up to five-fold upregulation of VE-cadherin after NPAS4 transfection in HUVECs within 24 h ( Figure 5B ). Vice versa, VE-cadherin expression decreased after downregulation of NPAS4 in HUVECs achieved by transfection of specific siRNAs ( Figure 5C ). Additionally, we performed an immunocytological staining of transfected HUVECs to visualize VE-cadherin after NPAS4 overexpression or knockdown in the cells. Consistent with our previous results NPAS4 overexpressing cells showed increased VE-cadherin expression ( Figure 5D ) and, on the contrary, knockdown of NPAS4 displayed decreased VE-cadherin expression ( Figure 5E ). To address the question if the VE-cadherin promoter contains NPAS4 binding motives and, thus, is directly regulated by NPAS4, we performed a bioinformatic analysis with a 1000 bp promotor sequence upstream to the transcription start site of the human and zebrafish VE-cadherin gene. Indeed, we detected the NPAS4 binding motif (CTCGTG) in close proximity to the transcription start site of the VE-cadherin promoter ( Figure 5F ). To show that this interaction is functionally relevant, we tested whether NPAS4 overexpression could enhance VE-cadherin promoter activity in a luciferase reporter assay ( Figure 5G ). NPAS4 overexpression resulted in an approximate 1.5-fold increased transactivation of VE-cadherin promoter activity. To investigate if the pro-angiogenic NPAS4 effect is mediated by VE-cadherin, we performed Matrigel assays with NPAS4 overexpression and added a VE-cadherin neutralizing/blocking antibody (BV9). Indeed, BV9 blocked NPAS4-induced tube formation in the Matrigel assay ( Figure 5H and I) . Taken together, these data suggest that VE-cadherin is one of the targets regulated by NPAS4.
NPAS4 regulates filopodia formation and the tip cell position of endothelial cells
As VE-cadherin is known to support migration 27, 28 for which filopodia are one fundamental basis, we investigated the formation of filopodia after NPAS4 modulation in endothelial cells. As a first step, we visualized filopodia formation in HUVECs by actin cytoskeleton staining. Cells were either transfected with the NPAS4-coding plasmid or with specific siRNAs blocking the expression of NPAS4 and cultured on glass cover slides coated with Matrigel. Overexpression of NPAS4 led to a significantly increased number and length of filopodia ( Figure 6A) . Consistently, NPAS4-deficient cells showed reduced filopodia formation ( Figure 6B) .
To further examine the role of NPAS4 in tip cell formation, we performed a mosaic spheroid-sprouting assay ( Figure 6C and D) . Mosaic spheroids were generated by mixing equal amounts of HUVECs either transfected with control and labelled with CMPTX (red) or with NPAS4 plasmid (or control) and labelled with CFDA-SE (green). This approach allows distinguishing the cell position within the developing sprout according to the cell treatment. Forty-eight hours post-transfection spheroids and sprouts were visualized by confocal microscopy. In doublecontrol spheroids, tip cells were built equally from both HUVEC populations ( Figure 6C and D, left panels) . However, if NPAS4 is overexpressed in the green cell population, most of the tip cells are formed by this group of cells and not by control treated cells ( Figure 6C, right panel) . Consistently, HUVECs that were depleted from NPAS4 expression by transfection of specific siRNA very rarely form tip cells compared with control cells ( Figure 6D) . To address the question if NPAS4 has an effect on tip cell formation on the molecular level, we analyzed mRNA expression of the tip cell marker delta-like 4 (DLL4) and detected increased DLL4 expression after NPAS4 overexpression and decreased DLL4 expression after silencing of NPAS4 ( Figure 6E) . Collectively, our findings support the notion NPAS4 promoted the tip cell position in endothelial cells by increasing filopodia formation. Moreover, NPAS4 is even necessary for the tip cell position as NPAS4 deficiency resulted in the disability of HUVECs to become a tip cell.
NPAS4 knockdown in zebrafish led to vascular malformations
As tip/stalk cell selection is necessary for proper blood vessel development, we next investigated the role of NPAS4 in the zebrafish as in vivo model. The transgenic zebrafish line fli:EGFP allows us to visualize vascularization in the developing embryo in vivo by expression of the enhanced green fluorescent protein in endothelial cells under control of the fli1-promoter. 24, 29 Using in situ hybridization, we detected the expression of NPAS4 in the region of the caudal vein and posterior cardinal vein in 24 hpf zebrafish supporting the notion that NPAS4 is related to blood vessel formation ( Figure 7A and B) . To investigate the function of NPAS4 in vivo, we used NPAS4-specific morpholinos to knockdown NPAS4 from developing embryos. Analysis of NPAS4 mRNA splicing by RT-PCR 48 h after MO injection showed a significant reduction in wildtype NPAS4 mRNA (Supplementary material online, Figure S4A ). In NPAS4 knockdown morphant embryos, the growth of intersegmental vessels is perturbed and inhibited in trunk and tail. The intersegmental vessels often stop to elongate through the somites and fail to form the dorsal longitudinal anastomotic vessel ( Figure 7C , B, D, F). About half of the embryos showed vascular malformations as depicted in the diagram in Figure 7D .
To address the question if observed malformations are due to possible morpholino induced off-target effects such as apoptosis, we also performed coinjections with p53 morpholino to attenuate apoptosis 30, 31 and an active Caspase 3 staining (Supplementary material online, Figure  S4B -E). Embryos coinjected with p53 morpholino (Supplementary ma terial online, Figure S4B e and f) showed the same vascular defects as embryos injected with NPAS4-specific morpholinos alone (Supplementary material online, Figure S4B c and d) . In addition, analysis of active Caspase 3 in embryos after control, NPAS4 or NPAS4/p53 MO injection did not show significant differences in the occurrence of apoptotic cells (Supplementary material online) . These results indicate that the observed morphant phenotypes are not due to off-target effects. Taken together, NPAS4 is expressed at the time and at sites of blood vessel development in the zebrafish embryo and, moreover, is necessary for proper blood vessel formation.
Discussion
In earlier work, we have shown that NPAS4 is a homologue of Drosophila Dysfusion and that it is highly expressed in brain tissue, particularly in the limbic system. 11 Here, we demonstrate for the first time that NPAS4 is also expressed by human endothelial cells of different origin (Figure 1) . NPAS4 promoted angiogenic endothelial cell function in several angiogenesis assays in vitro (Figures 2 and 6A, C) and, accordingly, loss of NPAS4 resulted in reduced angiogenesis in vitro and in vivo (Figures 3, 4 , 6B, D and 7C,D). We identified VE-cadherin to be regulated by NPAS4 ( Figure 5) . NPAS4 increased filopodia formation and supported endothelial cells to acquire the tip cell position ( Figure 6) . Furthermore, we showed that in the developing zebrafish embryo NPAS4 is necessary for regular blood vessel formation (Figure 7) . Previously, Lin et al. 17 have shown that the expression level of NPAS4 in neurons determined the number of functional GABAergic synapses. Besides its expression in brain tissue, NPAS4 has recently been shown to be also expressed in pancreatic islets. We have now detected NPAS4 expression in human endothelial cells of different origin (Figure 1) . In pancreatic islets, NPAS4 reduced ER stress and, thus, prevented cell death and maintains basal cell function. 32 These results suggest that NPAS4 is a key regulator for cell function and survival. Additionally, similar to its activating features in pancreatic bancreat NPAS4 promoted pro-angiogenic cell functions such as migration or sprout formation ( Figure 2) . Altogether, we identified a new role for the neuronal transcription factor NPAS4 in endothelial cells, which is now the second example for NPAS4 function in a non-neuronal tissue. Endothelial tip cells strongly resemble axonal growth cones concerning their structure and function. Both extend filopodia to probe their environment for guidance cues of which some are already known to be shared for axon guidance as well as blood vessel path finding. 33 A wellknown example is VEGF that besides its role in blood vessel formation regulates the development of the nervous system. 34 Interestingly, we have shown that overexpression of the neuronal transcription factor NPAS4 in HUVECs led to a significantly increased number and length of filopodia ( Figure 6A) . Moreover, overexpression of NPAS4 in HUVECs promoted the tip cell position whereas NPAS4 deficiency resulted in the disability of HUVECs to become a tip cell ( Figure 6D) . Finally, in zebrafish embryos, NPAS4 is necessary for proper development of intersegmental vessels, a process in which tip cells play a decisive role. Interestingly, we identified VE-cadherin as downstream target of NPAS4. In general, VE-cadherin plays a contradictory role in endothelial cells. Besides VE-cadherin's well-known characteristic to mediate adhesion in quiescent vessels, it is also crucial for angiogenesis. 27 For example, VE-cadherin expression is upregulated during vascular proliferation, interacts with fibrin to promote cell migration, mediates filopodia contact and promotes tip cell fusion. 28, 27, [35] [36] [37] Along this line, the NPAS4 orthologue in drosophila Dysfusion targets the adhesion molecules Shotgun and CG13196. 26 In fact, Shotgun is a member of the cadherin family with homologous cytoplasmic domains to vertebrate classical cadherins. 38, 26 Dysfusion is expressed in the tips of tracheal branches and is necessary for proper fusion of tracheal tubes. 13 In the absence of Dysfusion, filopodia of fusion cells may still come close to each other but cannot adhere so that fusion failed to occur. 13, 26 In sprouting angiogenesis tip, cells are crucial for capillary branching and anastomosis. 35 In the developing zebrafish embryo, anastomosis of intersegmental vessels in the dorsal regions of the trunk is required to form the dorsal longitudinal anastomotic vessels (DLAVs) at 36 hpf. 39 Recently, VE-cadherin was
shown to be localized in tip cell filopodia just prior to anastomosis,
The role of NPAS4 in angiogenesis The role of NPAS4 in angiogenesis indicating a role in mediating filopodia contact. 35, 36, 40 We have revealed that VE-cadherin is among the targets of NPAS4 in vitro ( Figure 5 ), but, we have not proven changes in VE-cadherin expression in vivo. Moreover, overexpression of NPAS4 increased filopodia formation and vice versa filopodia formation was reduced after knockdown of NPAS4 ( Figure 6 ). Strikingly, zebrafish embryos lacking NPAS4 often failed to form the DLAVs ( Figure 7C , D and F). Even at 72 hpf, wide parts of the DLAVs are still missing. As we have already hypothesized a regulatory role for NPAS4 in tip cell formation, it is tempting to speculate that NPAS4 may also be important for vessel anastomosis in vertebrates. Taken together, NPAS4 is a conserved transcription factor that controls in addition to sprouting and branching also fusion events in several organs across species. During revision of our manuscript, a very recent paper was published in Nature demonstrating that NPAS4 is related to the vascular zebrafish phenotype cloche, which when mutated led to the loss of nearly all endothelial and hematopoietic cells. Interestingly, they found that human NPAS4 was able to rescue the zebrafish cloche phenotype. 41 However,
NPAS4
-/-mice have no obvious vascular phenotype and survive to adulthood. 17 We and others hypothesize that this is due to feedback mechanisms by other bHLH-PAS transcription factors that compensate for NPAS4 deficiency during embryonic development. 41, 42 For example, frequencies of miniature inhibitory post-synaptic currents were similar in hippocampal slices prepared from NPAS4 þ/þ and NPAS4 -/-mice, whereas a clear difference was seen when NPAS4 was acutely reduce by RNAi compared with wildtype slices. 17 Similarly, reduction in the expression of certain NPAS4 target genes in NPAS4 global knockout mice was less pronounced than in the conditional deletion of NPAS4 in adult mice. 43 Indeed, we made similar observations in angiogenesis assays involving the global NPAS4 -/-mice and the RNAi experiments in zebrafish embryos. NPAS4 -/-mice showed no obvious differences in retina angiogenesis or the aortic ring assay. However, when Matrigel was injected endothelial ingrowth was reduced in NPAS4 -/-mice in particular under bFGF-stimulating conditions (Figure 4) . Moreover, RNAi inhibition in the developing zebrafish larvae by morpholinos also represents an acute model of NPAS4 reduction in vivo that showed a clear effect on angiogenesis. Regarding blood vessel formation members of the bHLH-PAS transcription factors such as hypoxia inducible factors are well known to play an important role. 2 As the retina mouse model revealed no difference between NPAS4 -/-mice and wildtype littermates, we assume that due to the hypoxic condition in the mouse retina HIF is upregulated and may compensate for the lack of NPAS4 in retinal angiogenesis. This is supported by a recent finding that during differentiation of human pluripotent stem cells into the endothelial cell lineage aryl hydrocarbon receptor (AHR) expression is increased as NPAS4 expression diminished suggesting that AHR may compensate for NPAS4. 41 These findings in conjunction with our data add the neuronal PAS bHLH transcription factor NPAS4 to the list of regulators in blood vessel formation.
A growing body of evidence indicates that angiogenesis, neuronal growth and formation of synapses or tracheal tube formation and fusion follow similar mechanisms and use comparable guiding cues, which are conserved among species. 33, 9 One important issue concerning common mechanism of organogenesis is the patterning in branching morphogenesis. In this regard, involved genes and signalling pathways are remarkably conserved across species as well as across different organs and cell types. 10 A well-known example is the fibroblast growth factor (FGF) family including the downstream signalling pathway to stimulate vessel branching, 44 branching of mammalian lung and insect trachea. 45 With regard to NPAS4, which plays a role in neurodevelopment as well as the drosophila orthologue Dysfusion controls the development of the insect trachea, we found that NPAS4 is necessary for endothelial cell function such as migration, sprouting and branch formation to build a new vasculature (Figure 7) . Moreover, NPAS4 is highly conserved in vertebrates. 11, 12 Taken together, these data suggest that NPAS4 is a common regulator involved in patterning mechanism across different organs and cell types. Therefore, NPAS4 is a promising candidate regarding further studies towards therapeutical neovascularization in cardiovascular diseases.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
